John P Reilly1, Brian J Anderson2, Nilam S Mangalmurti2, Tam D Nguyen2, Daniel N Holena3, Qufei Wu4, Ethan T Nguyen2, Muredach P Reilly5, Paul N Lanken2, Jason D Christie6, Nuala J Meyer2, Michael G S Shashaty6. 1. Divisions of Pulmonary, Allergy, and Critical Care and John.Reilly@uphs.upenn.edu. 2. Divisions of Pulmonary, Allergy, and Critical Care and. 3. Traumatology, Surgical Critical Care, and Emergency Surgery. 4. Center for Clinical Epidemiology and Biostatistics, and. 5. Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 6. Divisions of Pulmonary, Allergy, and Critical Care and Center for Clinical Epidemiology and Biostatistics, and.
Abstract
BACKGROUND AND OBJECTIVE: ABO blood types are determined by antigen modifications on glycoproteins and glycolipids and associated with altered plasma levels of inflammatory and endothelial injury markers implicated in AKI pathogenesis. We sought to determine the association of ABO blood types with AKI risk in critically ill patients with trauma or sepsis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted two prospective cohort studies at an urban, academic, level I trauma center and tertiary referral center; 497 patients with trauma admitted to the surgical intensive care unit between 2005 and 2010 with an injury severity score >15 and 759 patients with severe sepsis admitted to the medical intensive care unit between 2008 and 2013 were followed for 6 days for the development of incident AKI. AKI was defined by Acute Kidney Injury Network creatinine and dialysis criteria. RESULTS: Of 497 patients with trauma, 134 developed AKI (27%). In multivariable analysis, blood type A was associated with higher AKI risk relative to type O among patients of European descent (n=229; adjusted risk, 0.28 versus 0.14; risk difference, 0.14; 95% confidence interval, 0.03 to 0.24; P=0.02). Of 759 patients with sepsis, AKI developed in 326 (43%). Blood type A again conferred higher AKI risk relative to type O among patients of European descent (n=437; adjusted risk, 0.53 versus 0.40; risk difference, 0.14; 95% confidence interval, 0.04 to 0.23; P=0.01). Findings were similar when analysis was restricted to those patients who did not develop acute respiratory distress syndrome or were not transfused. We did not detect a significant association between blood type and AKI risk among individuals of African descent in either cohort. CONCLUSIONS: Blood type A is independently associated with AKI risk in critically ill patients with trauma or severe sepsis of European descent, suggesting a role for ABO glycans in AKI susceptibility.
BACKGROUND AND OBJECTIVE:ABO blood types are determined by antigen modifications on glycoproteins and glycolipids and associated with altered plasma levels of inflammatory and endothelial injury markers implicated in AKI pathogenesis. We sought to determine the association of ABO blood types with AKI risk in critically illpatients with trauma or sepsis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted two prospective cohort studies at an urban, academic, level I trauma center and tertiary referral center; 497 patients with trauma admitted to the surgical intensive care unit between 2005 and 2010 with an injury severity score >15 and 759 patients with severe sepsis admitted to the medical intensive care unit between 2008 and 2013 were followed for 6 days for the development of incident AKI. AKI was defined by Acute Kidney Injury Network creatinine and dialysis criteria. RESULTS: Of 497 patients with trauma, 134 developed AKI (27%). In multivariable analysis, blood type A was associated with higher AKI risk relative to type O among patients of European descent (n=229; adjusted risk, 0.28 versus 0.14; risk difference, 0.14; 95% confidence interval, 0.03 to 0.24; P=0.02). Of 759 patients with sepsis, AKI developed in 326 (43%). Blood type A again conferred higher AKI risk relative to type O among patients of European descent (n=437; adjusted risk, 0.53 versus 0.40; risk difference, 0.14; 95% confidence interval, 0.04 to 0.23; P=0.01). Findings were similar when analysis was restricted to those patients who did not develop acute respiratory distress syndrome or were not transfused. We did not detect a significant association between blood type and AKI risk among individuals of African descent in either cohort. CONCLUSIONS: Blood type A is independently associated with AKI risk in critically illpatients with trauma or severe sepsis of European descent, suggesting a role for ABOglycans in AKI susceptibility.
Authors: Hernando Gomez; Can Ince; Daniel De Backer; Peter Pickkers; Didier Payen; John Hotchkiss; John A Kellum Journal: Shock Date: 2014-01 Impact factor: 3.454
Authors: Timothy A Sutton; Henry E Mang; Silvia B Campos; Ruben M Sandoval; Mervin C Yoder; Bruce A Molitoris Journal: Am J Physiol Renal Physiol Date: 2003-04-08
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: Chirag V Shah; Paul N Lanken; A Russell Localio; Robert Gallop; Scarlett Bellamy; Shwu-Fan Ma; Carlos Flores; Jeremy M Kahn; Barbara Finkel; Barry D Fuchs; Joe G N Garcia; Jason D Christie Journal: Chest Date: 2010-06-24 Impact factor: 9.410
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Guillaume Paré; Daniel I Chasman; Mark Kellogg; Robert Y L Zee; Nader Rifai; Sunita Badola; Joseph P Miletich; Paul M Ridker Journal: PLoS Genet Date: 2008-07-04 Impact factor: 5.917
Authors: John P Reilly; Zhiguo Zhao; Michael G S Shashaty; Tatsuki Koyama; Jason D Christie; Paul N Lanken; Chunxue Wang; John R Balmes; Michael A Matthay; Carolyn S Calfee; Lorraine B Ware Journal: Am J Respir Crit Care Med Date: 2019-01-01 Impact factor: 21.405
Authors: Khalid Al Sulaiman; Nouf Al Qahtani; Mashael Al Muqrin; Maram Al Dossari; Ali Al Wabel; Tareq Al Sulaiman; Ramesh Vishwakarma; Abdulaziz Alolayan; Fatimah Abudayah; Ghazwa B Korayem; Ohoud Aljuhani Journal: J Int Med Res Date: 2022-07 Impact factor: 1.573
Authors: Nuala J Meyer; John P Reilly; Rui Feng; Jason D Christie; Stanley L Hazen; Carolyn J Albert; Jacob D Franke; Celine L Hartman; Jane McHowat; David A Ford Journal: JCI Insight Date: 2017-12-07
Authors: Jason D Christie; Nuala J Meyer; Brian J Anderson; John P Reilly; Michael G S Shashaty; Jessica A Palakshappa; Alex Wysoczanski; Thomas G Dunn; Altaf Kazi; Anna Tommasini; Mark E Mikkelsen; William D Schweickert; Dennis L Kolson Journal: J Crit Care Date: 2016-06-23 Impact factor: 3.425
Authors: Christian Bime; Nima Pouladi; Saad Sammani; Ken Batai; Nancy Casanova; Tong Zhou; Carrie L Kempf; Xiaoguang Sun; Sara M Camp; Ting Wang; Rick A Kittles; Yves A Lussier; Tiffanie K Jones; John P Reilly; Nuala J Meyer; Jason D Christie; Jason H Karnes; Manuel Gonzalez-Garay; David C Christiani; Charles R Yates; Mark M Wurfel; Gianfranco U Meduri; Joe G N Garcia Journal: Am J Respir Crit Care Med Date: 2018-06-01 Impact factor: 30.528
Authors: John P Reilly; Fan Wang; Tiffanie K Jones; Jessica A Palakshappa; Brian J Anderson; Michael G S Shashaty; Thomas G Dunn; Erik D Johansson; Thomas R Riley; Brian Lim; Jason Abbott; Caroline A G Ittner; Edward Cantu; Xihong Lin; Carmen Mikacenic; Mark M Wurfel; David C Christiani; Carolyn S Calfee; Michael A Matthay; Jason D Christie; Rui Feng; Nuala J Meyer Journal: Intensive Care Med Date: 2018-10-21 Impact factor: 17.440